NCT06149637

Brief Summary

The objective of this study is to compare shoulder and neck morbidity and the effectiveness of cervical lateral nodal dissection in patients with differentiated thyroid cancer and lateral metastases between the anterior and posterior approaches to the sternocleidomastoid muscle (SCM)

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
28mo left

Started Aug 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Aug 2023Aug 2028

Study Start

First participant enrolled

August 1, 2023

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

August 6, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 29, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2025

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2028

Expected
Last Updated

October 29, 2024

Status Verified

October 1, 2024

Enrollment Period

2.1 years

First QC Date

August 6, 2023

Last Update Submit

October 27, 2024

Conditions

Keywords

neck dissectionshoulder disfunctionrandomized clinical trial

Outcome Measures

Primary Outcomes (3)

  • Shoulder dysfunction

    (SPADI shoulder pain and disability questionnaire, validated in Spanish) Minimun score 0, maximun 100, a higher score means higher disability

    2 weeks, 3 months, 6 months, and 1 year

  • Cervical disconfort

    The Cervical Disability Index (IDC) validated in Spanish Minimun score 0, maximun 50, a higher score means higher disability

    2 weeks, 3 months, 6 months, and 1 year

  • Complications

    Temporary or permanent accessory nerve injury measured in the physical examination by limitation of the lateral range of movement of the shoulder less than 50% * Bleeding defined by the treating surgeon by physical examination * Wound infection: infection in the first 30 days after surgery, diagnosed with at least one of the following criteria: presence of purulent discharge from the surgical wound, presence of microorganisms isolated by taking a culture of wound discharge , presence of at least one of the signs and symptoms of inflammation (pain, redness, edema, heat). * Chylous fistula defined as milky discharge from the cervical drain with a triglyceride count higher than the serum. * Mortality * Re Operation before 30 days

    30 days

Secondary Outcomes (6)

  • Total lymph node count.

    30 days

  • Surgical time

    30 days

  • Lateral lymph node recurrence

    5 years

  • Dynamic response

    5 years

  • Overall and disease-free survival

    5 years

  • +1 more secondary outcomes

Study Arms (2)

Traditional neck dissection approach

ACTIVE COMPARATOR

Traditional neck dissection approach

Procedure: Traditional neck dissection approach

Anterior neck dissection approach

EXPERIMENTAL

Anterior neck dissection

Procedure: Anterior neck dissection approach

Interventions

.1. A transverse cervical incision is made with horizontal extension towards the affected side. 2. It is dissected through the subplatysmal plane, the posterior edge of the sternocleidomastoid muscle is dissected along its entire length. 3. Identification and dissection of the spinal nerve at Erb's point. 4. Level V nodes are dissected up to the spinal nerve without identifying or dissecting it 5. The jugular chain nodes are identified and the left level IV nodes are dissected with special attention to ligate the lymphatics of this level 6. Identification and dissection of level III nodes 7. Identification and dissection of level IIA and IIB ganglia with identification and preservation of the accessory nerve.

Traditional neck dissection approach

1. A transverse cervical incision is made with horizontal extension towards the affected side. 2. It is dissected through the subplatysmal plane, the anterior edge of the sternocleidomastoid muscle is dissected along its entire length. 3. Level V nodes are dissected up to the spinal nerve without identifying or dissecting it 4. The jugular chain nodes are identified and the left level IV nodes are dissected with special attention to ligate the lymphatics of this level 5. Identification and dissection of level III nodes 6. Identification and dissection of level IIA and IIB nodes with identification and preservation of the accessory nerve.

Anterior neck dissection approach

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients ≥ 18 years.
  • Patients with macroscopic lymph node involvement identified by physical examination, imaging or intraoperatively in lateral neck.
  • Patients with microscopic nodal involvement confirmed by FNAB (definition by the pathologist of suspected or confirmed metastatic papillary carcinoma according to the Bethesda criteria)
  • Candidates for lateral lymph node dissection due to suspected or confirmed disease metastatic lymph nodes as defined by the treating surgeon.
  • Patients requiring or not requiring thyroidectomy and/or central dissection concomitant with the dissection

You may not qualify if:

  • Patients with a history of previous neck dissection
  • Histological confirmation of medullary or anaplastic carcinoma
  • Previous spinal nerve injury

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Alma Mater de Antioquia

Medellín, Antioquia, 050010, Colombia

RECRUITING

MeSH Terms

Conditions

Thyroid Neoplasms

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesThyroid Diseases

Study Officials

  • Alvaro Sanabria

    Universidad de Antioquia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alvaro Sanabria, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Single (Participant)
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized, parallel, multicenter stratified clinical trial with 1:1 allocation.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Primary Researcher

Study Record Dates

First Submitted

August 6, 2023

First Posted

November 29, 2023

Study Start

August 1, 2023

Primary Completion

August 31, 2025

Study Completion (Estimated)

August 31, 2028

Last Updated

October 29, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations